Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome.
Allen
Richard
R
Department of Neurology, Johns Hopkins University, Bayview Medical Center, Baltimore, MD 21224, USA. richardJHU@aol.com
Becker
Philip M
PM
Bogan
Richard
R
Schmidt
Markus
M
Kushida
Clete A
CA
Fry
June M
JM
Poceta
J Steven
JS
Winslow
David
D
D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D020189:Nocturnal Myoclonus Syndrome / Q000188:drug therapy*; D017286:Polysomnography / Q000295:instrumentation; D012148:Restless Legs Syndrome / Q000188:drug therapy*; D012895:Sleep, REM / Q000187:drug effects
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D007211:Indoles; C046649:ropinirole